Ischemia enhances use-Dependent sodium channel blockade by pilsicainide, a class IC antiarrhythmic agent

This publication has 10 references indexed in Scilit:

• Experimental models of reentry, antiarrhythmic, and proarrhythmic actions of drugs. Complexities galore!
  Circulation, 1991
• Proarrhythmic response to sodium channel blockade. Theoretical model and numerical experiments.
  Circulation, 1991
• Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
  New England Journal of Medicine, 1991
• CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
  Circulation, 1990
• The cardiac arrhythmia suppression trial: Background, interim results and implications
  The American Journal of Cardiology, 1990
• Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction
  New England Journal of Medicine, 1989
• Amplification of flecainide-induced ventricular conduction slowing by exercise. A potentially significant clinical consequence of use-dependent sodium channel blockade.
  Circulation, 1989
• Effect of SUN 1165, a New Potent Antiarrhythmic Agent, on the Kinetics of Rate-Dependent Block of Na Channels and Ventricular Conduction of Extrasystoles
  Journal of Cardiovascular Pharmacology, 1988
• Antiarrhythmic agents: modulated receptor applications.
  Circulation, 1987
• The influence of pH on th electrophysiological effects of lidocaine in guinea pig ventricular myocardium.
  Circulation Research, 1980